Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
| Product: | Lithium Carbonate |
| Active Ingredient: | Lithium carbonate 250mg |
| Dosage Form: | Capsule |
| New Zealand Sponsor: | Douglas Pharmaceuticals Limited |
| Manufacturer: | Douglas Manufacturing Limited, Auckland, New Zealand |
| Product: | Opdivo (40mg/4ml) |
| Active Ingredient: | Nivolumab 10mg/mL |
| Dosage Form: | Concentrate for infusion |
| New Zealand Sponsor: | Bristol-Myers Squibb (NZ) Limited |
| Manufacturers: | Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany Bristol-Myers Squibb Holdings Pharma Limited, Manati, Puerto Rico |
| Product: | Opdivo (100mg/10ml) |
| Active Ingredient: | Nivolumab 10mg/mL |
| Dosage Form: | Concentrate for infusion |
| New Zealand Sponsor: | Bristol-Myers Squibb (NZ) Limited |
| Manufacturers: | Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany Bristol-Myers Squibb Holdings Pharma Limited, Manati, Puerto Rico |
| Product: | Soliris |
| Active Ingredient: | Eculizumab 300mg |
| Dosage Form: | Solution for infusion |
| New Zealand Sponsor: | Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics |
| Manufacturers: | Patheon Italia S.p.A, Milan, Italy Alexion Pharma International Operations Unlimited Company, Athlone, Ireland |
Dated this 6th day of June 2023.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).